Reaction
Multiple Congenital Abnormalities reporting signals
As of the last recalculation, Multiple Congenital Abnormalities appears in 1,436 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is PAROXETINE HYDROCHLORIDE (PRR 39.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Paroxetine Hydrochloride | 213 | 39.7 | 39.8 |
| Divalproex Sodium | 110 | 37.0 | 37.1 |
| Valproate Sodium | 38 | 27.3 | 27.4 |
| Hydrocodone Bitartrate And Acetaminophen | 91 | 24.9 | 25.0 |
| Misoprostol | 14 | 21.0 | 21.1 |
| Labetalol | 18 | 19.8 | 19.8 |
| Valproic Acid | 29 | 13.6 | 13.6 |
| Hydromorphone Hydrochloride | 80 | 13.3 | 13.3 |
| Oxycodone Hydrochloride | 164 | 12.2 | 12.2 |
| Efavirenz | 9 | 11.8 | 11.8 |
| Nevirapine | 7 | 11.3 | 11.3 |
| Lamotirigine | 53 | 11.1 | 11.1 |
| Lamotrigine Extended-Release | 53 | 11.1 | 11.1 |
| Lamotrigine Chewable Dispersible | 53 | 11.1 | 11.1 |
| Methadone Hydrochloride | 8 | 10.8 | 10.8 |
| Zonisamide | 10 | 9.9 | 9.9 |
| Lamotrigine | 83 | 9.6 | 9.6 |
| Oxazepam | 14 | 9.5 | 9.5 |
| Raltegravir | 10 | 8.8 | 8.8 |
| Insulin Glargine-Yfgn | 13 | 8.7 | 8.7 |
| Morphine Sulfate | 68 | 8.5 | 8.5 |
| Hydrocodone Bitartrate | 25 | 8.5 | 8.5 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 11 | 6.7 | 6.7 |
| Oxymorphone Hydrochloride | 5 | 6.2 | 6.2 |
| Buprenorphine | 37 | 5.9 | 5.9 |
| Vigabatrin | 3 | 3.0 | 3.0 |